These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7576029)

  • 1. Allogenic vascularized transplantation of a human femoral diaphysis under cyclosporin A immunosuppression.
    Hofmann GO; Kirschner MH; Bühren V; Land W
    Transpl Int; 1995; 8(5):418-9. PubMed ID: 7576029
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogenic grafting of vascularized bone segments under immunosuppression. Clinical results in the transplantation of femoral diaphyses.
    Kirschner MH; Wagner FD; Nerlich A; Land W; Bühren V; Hofmann GO
    Transpl Int; 1998; 11(3):195-203. PubMed ID: 9638848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of arterial blood supply to the femur and tibia for transplantation of vascularized femoral diaphyses and knee joints.
    Kirschner MH; Menck J; Hennerbichler A; Gaber O; Hofmann GO
    World J Surg; 1998 Aug; 22(8):845-51; discussion 852. PubMed ID: 9673557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience in allogeneic vascularized bone and joint allografting.
    Hofmann GO; Kirschner MH
    Microsurgery; 2000; 20(8):375-83. PubMed ID: 11150987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints--first clinical experiences.
    Hofmann GO; Kirschner MH; Wagner FD; Brauns L; Gonschorek O; Bühren V
    Transplant Proc; 1998 Sep; 30(6):2754-61. PubMed ID: 9745561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-derived neoangiogenesis with short-term immunosuppression allows incorporation and remodeling of vascularized diaphyseal allogeneic rabbit femur transplants.
    Giessler GA; Zobitz M; Friedrich PF; Bishop AT
    J Orthop Res; 2009 Jun; 27(6):763-70. PubMed ID: 19023894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revascularized intercalary bone allografts with short-term immunosuppression with cyclosporine in the canine.
    Doi K; Akino T; Shigetomi M; Muramatsu K; Kawai S
    Plast Reconstr Surg; 1998 Mar; 101(3):793-801. PubMed ID: 9500398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogeneic vascularized transplantation in cases of bone and joint defects].
    Hofmann GO; Kirschner MH; Gonschorek O; Bühren V
    Unfallchirurg; 1999 Jun; 102(6):458-65. PubMed ID: 10420826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characteristics of biochemical parameters during consupren therapy after allogenic transplantation of the kidney.
    Denisova NA; Pletneva TV; Baikova VN; Berezov TT
    Bull Exp Biol Med; 2004 Oct; 138(4):407-11. PubMed ID: 15665958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
    Vanrenterghem Y; Peeters J
    Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
    [No Abstract]   [Full Text] [Related]  

  • 11. [Twenty-five years of cyclosporin use in transplantation medicine].
    Hesselink DA; van Hagen PM; Balk AH; van Hal PT; Weimar W; van Gelder T
    Ned Tijdschr Geneeskd; 2003 May; 147(20):959-64. PubMed ID: 12784529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of three-phase bone scans and SPET in the follow-up of patients with allogenic vascularized femur transplants.
    Kirschner MH; Manthey N; Tatsch K; Nerlich A; Hahn K; Hofmann GO
    Nucl Med Commun; 1999 Jun; 20(6):517-24. PubMed ID: 10451863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine as a milestone in immunosuppression.
    Calne R
    Transplant Proc; 2004 Mar; 36(2 Suppl):13S-15S. PubMed ID: 15041300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fresh venous allografts in peripheral arterial reconstruction in dogs. Effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil.
    Wagner E; Roy R; Marois Y; Douville Y; Guidoin R
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1732-44. PubMed ID: 8523886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression with cyclosporin A in combination with mycophenolate mofetil suppresses rejection of allogeneic fetal rat pancreatic allografts.
    du Toit DF; Muller C; Page B; Mattysen J; Lyners R
    Transplant Proc; 1998 Dec; 30(8):4092-3. PubMed ID: 9865308
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in renal transplant patient.
    Jones TR; Humphrey PA; Brennan DC
    Transplant Proc; 1998 Sep; 30(6):2746-53. PubMed ID: 9745560
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
    Sato K; Yokota K; Matsui T; Imai K; Takishima T; Nakayama Y; Osakabe T; Yoshida M; Mieno H; Omiya H
    Transplant Proc; 1991 Dec; 23(6):3296-9. PubMed ID: 1721440
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress with cyclosporine-sparing regimens.
    Grinyó JM
    Transplant Proc; 1999 Dec; 31(8A):11S-16S. PubMed ID: 10616555
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoral cyclosporine as maintenance immunosuppression in pediatric small bowel transplantation.
    Atkison P; Williams S; Howard J; Wall W; Paradis K; Seidman E; Grant D
    Transplant Proc; 1998 Aug; 30(5):1973-4. PubMed ID: 9723357
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogeneic vascularized grafting of human knee joints under postoperative immunosuppression of the recipient.
    Hofmann GO; Kirschner MH; Wagner FD; Brauns L; Gonschorek O; Bühren V
    World J Surg; 1998 Aug; 22(8):818-23. PubMed ID: 9673553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.